National and Kapodistrian University of Athens
Μελέτη της πρωτεΐνης heat shock protein 90 (HSP90) σε καρκινικά φαινόμενα
Abstract
dc:descriptionCancer is a class of diseases in which a group of cells display uncontrolled growth intrusion an and destruction of adjacent tissues (invasion), and sometimes spread to other locations in the body via lymph or blood creating metastases. Heat shock protein 90 (HSP90) is a chaperone protein that is essential for the cell to stabilize the form and the function of a variety of substrates. Moreover, HSP90 interacts with a great number of molecules that are involved in the development and low survival of cancer cells. In order to understand the molecular events regulating neuronal migration and development, we have previously characterized a monoclonal antibody (mAb), named 4C5. This antibody recognizes both HSP90 isoforms. The primary aim of the present study was to evaluate the potential prognostic value of mAb4C5 in malignant melanoma. Interestingly, mAb4C5 reacted positively in all the primary and metastatic melanomas examined, while the cell surface localization of HSP90 was shown immunohistochemically on live B16 F10 melanoma cells using mAb4C5. To assess the participation of cell surface and not intracellular HSP90 in the invasion process of B16 F10 melanoma cells, internalization of mAb4C5 and anti-alpha HSP90 and anti-beta HSP90 antibodies in the culture medium strongly inhibited melanoma cell invasion in vitro. The above described experiments showed that mAB4C5 had the ability to inhibit melanoma cell invasion in vitro, and since it could not be internalized, the inhibition of the invasion could be attributed to the surface pool of HSP90 molecules. In line with these experiments it was shown that mAb4C5 could inhibit melanoma metastasis in vivo using B16 F10 cells and C57/BL mice. As a next step the molecular mechanisms of the surface HSP90 were investigated. This study revealed that both isoforms of HSP90 were secreted from human breast cancer cells (MOAMB453) and that both isoforms interact with MMPs (Matrix metaloproteinases 2 and 9). Furthermore, mAb4C5 could inhibit: a) the activation of these molecules in vitro and b) the metastatic despositions of MOAMB453 cells in vivo mouse models, suggesting that mAb4C5 could be a potential anticancer agent.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stellas, Dimitris
- Στέλλας, Δημήτριος
Subjects
dc:subject × 22- Πρωτεΐνη θερμικού σοκ 90
- Μεταστάσεις
- Καρκίνος
- Αντίσωμα MAB4C5
- Διήθηση
- Μεταλλοπρωτεϊνάση-2
- Μεταλλοπρωτεϊνάση-9
- Heat shock protein 90
- Hsp90
- Matrix Metalloproteinase-2 (Mmp-2)
- Matrix metalloproteinase-9
- Monoclonal antibodies
- MAB4C5
- Cancer
- Metastasis
- Invasion
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Basic Medicine
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28145